- Home
- PTPI vs PTIX Comparison
PTPI vs PTIX Comparison
Compare PTPI & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTPI
- PTIX
- Stock Information
- Founded
- PTPI 2020
- PTIX 1994
- Country
- PTPI United States
- PTIX United States
- Employees
- PTPI N/A
- PTIX N/A
- Industry
- PTPI Biotechnology: Pharmaceutical Preparations
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- PTPI Health Care
- PTIX Health Care
- Exchange
- PTPI Nasdaq
- PTIX Nasdaq
- Market Cap
- PTPI 2.2M
- PTIX 1.9M
- IPO Year
- PTPI N/A
- PTIX 2016
- Fundamental
- Price
- PTPI $0.13
- PTIX $3.03
- Analyst Decision
- PTPI
- PTIX
- Analyst Count
- PTPI 0
- PTIX 0
- Target Price
- PTPI N/A
- PTIX N/A
- AVG Volume (30 Days)
- PTPI 16.9M
- PTIX 259.3K
- Earning Date
- PTPI 05-27-2025
- PTIX 05-27-2025
- Dividend Yield
- PTPI N/A
- PTIX N/A
- EPS Growth
- PTPI N/A
- PTIX N/A
- EPS
- PTPI N/A
- PTIX N/A
- Revenue
- PTPI $5,112,043.00
- PTIX N/A
- Revenue This Year
- PTPI $9.25
- PTIX N/A
- Revenue Next Year
- PTPI N/A
- PTIX N/A
- P/E Ratio
- PTPI N/A
- PTIX N/A
- Revenue Growth
- PTPI 54.70
- PTIX N/A
- 52 Week Low
- PTPI $0.12
- PTIX $2.51
- 52 Week High
- PTPI $18.00
- PTIX $26.18
- Technical
- Relative Strength Index (RSI)
- PTPI 28.96
- PTIX 45.51
- Support Level
- PTPI $0.10
- PTIX $2.82
- Resistance Level
- PTPI $0.20
- PTIX $3.68
- Average True Range (ATR)
- PTPI 0.10
- PTIX 0.54
- MACD
- PTPI 0.04
- PTIX 0.03
- Stochastic Oscillator
- PTPI 3.57
- PTIX 37.16
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.